Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
796 Pegylated liposomal doxorubicin chemotherapy, Flt3 ligand, and CD40 agonist triplet combination improves tumor control in breast cancers
Compose a Response to This Article
Other responses
No responses have been published for this article.